Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

Lancet. 2021 Jul 31;398(10298):385-387. doi: 10.1016/S0140-6736(21)01642-1. Epub 2021 Jul 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • BNT162 Vaccine
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / immunology*
  • COVID-19 Vaccines / therapeutic use
  • ChAdOx1 nCoV-19
  • Female
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology*
  • Spike Glycoprotein, Coronavirus / blood
  • Spike Glycoprotein, Coronavirus / immunology*
  • Time Factors

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ChAdOx1 nCoV-19
  • BNT162 Vaccine